Article
Current and Future Treatments for Classic Galactosemia
28 Jan 2021
Abstract excerpt
Type I (classic) galactosemia, galactose 1-phosphate uridylyltransferase (GALT)-deficiency is a hereditary disorder of galactose metabolism. The current therapeutic standard of care, a galactose-restricted diet, is effective in treating neonatal complications but is inadequate in preventing burdensome complications. The development of several animal models of classic galactosemia that (partly) mimic the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
